Federal award (DEFINITIVE CONTRACT, fiscal year 2024)
Recipient: NEW YORK MEDICAL COLLEGE
Awarding agency: Department of Health and Human Services / Food and Drug Administration
Funding agency: Department of Health and Human Services / Food and Drug Administration
Period of performance: 2022-09-26 to 2027-09-27
Current total value of award: $2573555.62
Description: TO CHARACTERIZE THE CLINICAL PRESENTATION OF C-VAM/TO CONTRAST C-VAM WITH CARDIAC COMPLICATIONS OF INFECTION WITH SARS-COV-2 THAT THE IMMUNIZATION SEEKS TO PREVENT/TO INFORM BEST PRACTICES FOR SURVEILLANCE AND MONITORING FOR C-VAM, INCLUDING IN ASYMP